Christopher T. Jagoe

Christopher T. Jagoe is a patent litigator whose career has focused on complex disputes in the pharmaceutical, chemical, and life sciences sectors. With a Ph.D. in Organic Chemistry, he has extensive experience in matters involving medicinal chemistry, medical devices, polymers, and biofuels. Public records document a lengthy career as a partner at Kirkland & Ellis and, prior to that, at Kaye Scholer, where he represented major industry clients such as Pfizer and Actavis in significant litigations, including ANDA cases. His work has included representing patentees as well as generic drug manufacturers, with notable outcomes including a Federal Circuit decision affirming an invalidity judgment for client Actavis concerning a patent on the drug Neupro.

According to available case data, Mr. Jagoe is of counsel at Kilpatrick Townsend & Stockton. In this role, he has represented plaintiff DISH Technologies L.L.C. in its patent litigation against fuboTV Inc. This plaintiff-side representation in the technology sector is a departure from his publicly documented history, which is heavily concentrated on defense-side work for pharmaceutical and chemical companies. His affiliation with Kilpatrick Townsend is not detailed in readily available public biographies, which primarily document his long tenure at Kirkland & Ellis.

Mr. Jagoe is a registered patent attorney with the U.S. Patent and Trademark Office. He earned his J.D. from Fordham University School of Law, a Ph.D. in Organic Chemistry from Boston College, and a B.S. from the University of Connecticut.